2017 / 06

Следующая статья
DOI: 10.24075/vrgmu.2017-06-11

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ

Влияние типа анестезии и условий прокрашивания тканей мозга красителем 2,3,5-трифенилтетразолием хлористым (ТТХ) на оценку ишемического повреждения мозга крыс на ранних стадиях патогенеза

Д. С. Билан1,2, И. В. Кельмансон1, В. В. Белоусов1,2
Информация об авторах

1 Лаборатория молекулярных технологий,
Институт биоорганической химии имени академиков М. М. Шемякина и Ю. А. Овчинникова РАН, Москва

2 Отдел нейро-компьютерных интерфейсов, НИИ трансляционной медицины,
Российский национальный исследовательский медицинский университет имени Н. И. Пирогова, Москва

Для корреспонденции: Белоусов Всеволод Вадимович
ул. Миклухо-Маклая, д. 16/10, г. Москва, 117997; ur.hcbi@vosuoleb

Информация о статье

Финансирование: работа выполнена при поддержке Российского научного фонда, грант № 17-15-01175.

Вклад всех авторов в работу равнозначен: подбор и анализ литературы, планирование исследования, сбор, анализ и интерпретация данных, подготовка черновика рукописи, внесение исправлений.

Статья получена: 29.11.2017 Статья принята к печати: 10.12.2017 Опубликовано online: 25.01.2018
|
  1. who.int [Internet]. World Health Organisation WHO. The top 10 causes of death; c2016 [cited Jan 2012]. Available from: http://www.who.int/mediacentre/factsheets/fs310/en/.
  2. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K et al. Heart disease and stroke statistics–2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009; 119 (3): e21–181. DOI: 10.1161/CIRCULATIONAHA.108.191261.
  3. Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013 Nov; 1 (5): e259–81. DOI: 10.1016/S2214-109X(13)70089-5.
  4. Стаховская Л. В., Ключихина О. А., Богатырева М. Д., Коваленко В. В. Эпидемиология инсульта в России по результатам территориально-популяционного регистра (2009–2010). Журнал невропатологии и психиатрии им. С. С. Корсакова. 2013; 113 (5): 4–10.
  5. Papadopoulos SM, Chandler WF, Salamat MS, Topol EJ, Sackellares JC. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke. J Neurosurg. 1987 Sep; 67 (3): 394–8. DOI: 10.3171/jns.1987.67.3.0394.
  6. Busch E, Kruger K, Hossmann KA. Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat. Brain Res. 1997 Dec 5; 778 (1): 16–24.
  7. Roos MW, Ericsson A, Berg M, Sperber GO, Sjoquist M, Meyerson BJ. Functional evaluation of cerebral microembolization in the rat. Brain Res. 2003 Jan 24; 961 (1): 15–21.
  8. Watson BD, Dietrich WD, Busto R, Wachtel MS, Ginsberg MD. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann Neurol. 1985 May; 17 (5): 497–504. DOI: 10.1002/ana.410170513.
  9. Sharkey J, Ritchie IM, Kelly PA. Perivascular microapplication of endothelin-1: a new model of focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab. 1993 Sep; 13 (5): 865–71. DOI: 10.1038/jcbfm.1993.108.
  10. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1981; 1 (1): 53–60. DOI: 10.1038/jcbfm.1981.6.
  11. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav. 2007 May; 87 (1): 179–97. DOI: 10.1016/j.pbb.2007.04.015.
  12. Fluri F, Schuhmann MK, Kleinschnitz C. Animal models of ischemic stroke and their application in clinical research. Drug Des Devel Ther. 2015 Jul 2; 9: 3445–54. DOI: 10.2147/DDDT.S56071.
  13. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G. Experimental studies of ischemic brain edema: 1. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn Stroke J. 1986; 8: 1–8.
  14. Uluc K, Miranpuri A, Kujoth GC, Akture E, Baskaya MK. Focal cerebral ischemia model by endovascular suture occlusion of the middle cerebral artery in the rat. J Vis Exp. 2011 Feb 5; (48). pii: 1978. DOI: 10.3791/1978.
  15. Engel O, Kolodziej S, Dirnagl U, Prinz V. Modeling stroke in mice - middle cerebral artery occlusion with the filament model. J Vis Exp. 2011 Jan 6; (47). pii: 2423. DOI: 10.3791/2423.
  16. Garcia JH, Yoshida Y, Chen H, Li Y, Zhang ZG, Lian J et al. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol. 1993 Feb; 142 (2): 623–35.
  17. Zhang RL, Chopp M, Jiang N, Tang WX, Prostak J, Manning AM et al. Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat. Stroke. 1995 Aug; 26 (8): 1438–42; discussion 1443.
  18. Li H, Zhang N, Lin HY, Yu Y, Cai QY, Ma L et al. Histological, cellular and behavioral assessments of stroke outcomes after photothrombosis-induced ischemia in adult mice. BMC Neurosci. 2014 May 2; 15: 58. DOI: 10.1186/1471-2202-15-58.
  19. Rousselet E, Kriz J, Seidah NG. Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining. J Vis Exp. 2012; (69). pii: 4038. DOI: 10.3791/4038.
  20. de Olmos JS, Beltramino CA, de Olmos de Lorenzo S. Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicol Teratol. 1994 Nov-Dec; 16 (6): 545–61.
  21. Vogel J, Mobius C, Kuschinsky W. Early delineation of ischemic tissue in rat brain cryosections by high-contrast staining. Stroke. 1999 May; 30 (5): 1134–41.
  22. Schmued LC, Albertson C, Slikker W Jr. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 1997 Mar 14; 751 (1): 37–46.
  23. Schmued LC, Hopkins KJ. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 2000 Aug 25; 874 (2): 123–30.
  24. Schmued LC, Stowers CC, Scallet AC, Xu L. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res. 2005 Feb 21; 1035 (1): 24–31. DOI: 10.1016/j.brainres.2004.11.054.
  25. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, et al. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986 Nov-Dec; 17 (6): 1304–8.
  26. Linnik MD, Miller JA, Sprinkle-Cavallo J, Mason PJ, Thompson FY, Montgomery LR et al. Apoptotic DNA fragmentation in the rat cerebral cortex induced by permanent middle cerebral artery occlusion. Brain Res Mol Brain Res. 1995; 32 (1): 116–24. DOI: 10.1016/0169-328X(95)00069-5.
  27. Xu XH, Zhang SM, Yan WM, Li XR, Zhang HY, Zheng XX. Development of cerebral infarction, apoptotic cell death and expression of X-chromosome-linked inhibitor of apoptosis protein following focal cerebral ischemia in rats. Life Sci. 2006 Jan 11; 78 (7): 704–12. DOI: 10.1016/j.lfs.2005.05.080.
  28. Doyle FH, Pennock JM, Orr JS, Gore JC, Bydder GM, Steiner RE, et al. Imaging of the brain by nuclear magnetic resonance. Lancet. 1981; 2 (8237): 53–7.
  29. Kuhl DE, Phelps ME, Kowell AP, Metter EJ, Selin C, Winter J. Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18FDG and 13NH3. Ann Neurol. 1980; 8 (1): 47–60.
  30. Lassen NA, Henriksen L, Paulson O. Regional cerebral blood flow in stroke by 133Xenon inhalation and emission tomography. Stroke. 1981; 12 (3): 284–8.
  31. Zille M, Farr TD, Przesdzing I, Muller J, Sommer C, Dirnagl U et al. Visualizing cell death in experimental focal cerebral ischemia: promises, problems, and perspectives. J Cereb Blood Flow Metab. 2012 Feb; 32 (2): 213–31. DOI: 10.1038/jcbfm.2011.150.
  32. Liu S, Zhen G, Meloni BP, Campbell K, Winn HR. Rodent Stroke Model Guidelines for Preclinical Stroke Trials (1st Edition). J Exp Stroke Transl Med. 2009 Jan 1; 2 (2): 2–27.
  33. Stroke Therapy Academic Industry Roundtable II (STAIR-II). Recommendations for clinical trial evaluation of acute stroke therapies. Stroke. 2001 Jul; 32 (7): 1598–606.
  34. Fisher M, Albers GW, Donnan GA, Furlan AJ, Grotta JC, Kidwell CS et al. Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable. Stroke. 2005; 36 (8): 1808–13.
  35. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009 Jun; 40 (6): 2244–50. DOI: 10.1161/STROKEAHA.108.541128.
  36. Popp A, Jaenisch N, Witte OW, Frahm C. Identification of ischemic regions in a rat model of stroke. PLoS One. 2009; 4 (3): e4764. DOI: 10.1371/journal.pone.0004764.
  37. Liu F, Schafer DP, McCullough LD. TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion. J Neurosci Methods. 2009 Apr 30; 179 (1): 1–8. DOI: 10.1016/j.jneumeth.2008.12.028.
  38. Benedek A, Moricz K, Juranyi Z, Gigler G, Levay G, Harsing LG et al. Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats. Brain Res. 2006 Oct 20; 1116 (1): 159–65. DOI: 10.1016/j.brainres.2006.07.123.
  39. Jiang LJ, Zhang SM, Li CW, Tang JY, Che FY, Lu YC. Roles of the Nrf2/HO-1 pathway in the anti-oxidative stress response to ischemia-reperfusion brain injury in rats. Eur Rev Med Pharmacol Sci. 2017 Apr; 21 (7): 1532–40.
  40. Si J, Chen L, Xia Z. Effects of cervical-lymphatic blockade on brain edema and infarction volume in cerebral ischemic rats. Chin J Physiol. 2006 Oct 31; 49 (5): 258–65.
  41. Deng YH, He HY, Yang LQ, Zhang PY. Dynamic changes in neuronal autophagy and apoptosis in the ischemic penumbra following permanent ischemic stroke. Neural Regen Res. 2016 Jul; 11 (7): 1108–14. DOI: 10.4103/1673-5374.
  42. Morris GP, Wright AL, Tan RP, Gladbach A, Ittner LM, Vissel B. A Comparative study of variables influencing ischemic injury in the longa and Koizumi methods of intraluminal filament middle cerebral artery occlusion in mice. PLoS One. 2016 Feb 12; 11 (2): e0148503. DOI: 10.1371/journal.pone.0148503.
  43. Park HS, Han KH, Shin JA, Park JH, Song KY, Kim DH. The neuroprotective effects of carnosine in early stage of focal ischemia rodent model. J Korean Neurosurg Soc. 2014 Mar; 55 (3): 125–30. DOI: 10.3340/jkns.2014.55.3.125.
  44. Matsuda F, Sakakima H, Yoshida Y. The effects of early exercise on brain damage and recovery after focal cerebral infarction in rats. Acta Physiol (Oxf). 2011 Feb; 201 (2): 275–87. DOI: 10.1111/j.1748-1708.2010.02174.x.
  45. Chiang T, Messing RO, Chou WH. Mouse model of middle cerebral artery occlusion. J Vis Exp. 2011 Feb 13; (48). pii: 2761. DOI: 10.3791/2761.
  46. Dettmers C, Hartmann A, Rommel T, Kramer S, Pappata S, Young A, et al. Immersion and perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) compared to mitochondrial enzymes 6 hours after MCA-occlusion in primates. Neurol Res. 1994; 16 (3): 205–8.
  47. Zheng S, Zuo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol Pharmacol. 2004 May; 65 (5): 1172–80. DOI: 10.1124/mo;.65.5.1172.
  48. Chen F, Long Z, Yin J, Zuo Z, Li H. Isoflurane post-treatment improves outcome after an embolic stroke in rabbits. PLoS One. 2015; 10 (12): e0143931. DOI: 10.1371/journal.pone.0143931.
  49. Sun M, Deng B, Zhao X, Gao C, Yang L, Zhao H et al. Isoflurane preconditioning provides neuroprotection against stroke by regulating the expression of the TLR4 signalling pathway to alleviate microglial activation. Sci Rep. 2015 Jun 18; 5: 11445. DOI: 10.1038/srep11445.
  50. Christophe M, Nicolas S. Mitochondria: a target for neuroprotective interventions in cerebral ischemia-reperfusion. Curr Pharm Des. 2006; 12 (6): 739–57.
  51. Solenski NJ, diPierro CG, Trimmer PA, Kwan AL, Helm GA. Ultrastructural changes of neuronal mitochondria after transient and permanent cerebral ischemia. Stroke. 2002 Mar; 33 (3): 816–24.
  52. Liszczak TM, Hedley-Whyte ET, Adams JF, Han DH, Kolluri VS, Vacanti FX, et al. Limitations of tetrazolium salts in delineating infarcted brain. Acta Neuropathol. 1984; 65 (2): 150–7.